Gastrointestinal Videoscopes Market by Scope Type (Colonoscope, Duodenoscope, Enteroscope), Device Type (Reusable, Single Use), Resolution, Technology, Application, End User - Global Forecast 2025-2032
Description
The Gastrointestinal Videoscopes Market was valued at USD 10.36 billion in 2024 and is projected to grow to USD 12.12 billion in 2025, with a CAGR of 16.90%, reaching USD 36.16 billion by 2032.
A focused introduction that frames the gastrointestinal videoscopes landscape, clinical applications, and the analytical approach guiding strategic insights
The gastrointestinal videoscopes market sits at the nexus of clinical need, technological innovation, and evolving infection control expectations. This report opens with a concise orientation to the landscape, articulating the devices under consideration, the primary clinical applications they serve, and the operational environments in which they are deployed. The introduction frames the report’s scope and methodology while laying out the key themes that recur throughout the analysis, including device lifecycle management, reprocessing practices, and image resolution trends that influence purchasing decisions and clinical workflows.
Clinicians and administrators alike face a balance between patient safety, procedural efficiency, and capital planning. Therefore, the narrative emphasizes how incremental improvements in imaging and sensor technology can translate into diagnostic clarity and therapeutic precision. The introduction underscores the interplay between regulatory expectations and commercial strategy, setting the stage for subsequent sections that examine market shifts, tariff impacts, segmentation-level insights, and regional dynamics. By establishing this foundation, readers will gain clarity on the report’s objectives and the analytical lenses applied to synthesize cross-functional intelligence for stakeholders across clinical, procurement, and manufacturing roles.
Transformative shifts reshaping clinical practice, device stewardship, and commercial competition as safety, imaging performance, and single-use options gain prominence
The landscape for gastrointestinal videoscopes is undergoing transformative shifts driven by converging pressures from clinicians, regulators, and technology providers. Advances in sensor architectures and optics are improving image fidelity, while the rise of single-use devices is reshaping conversations about infection control, operational throughput, and total cost of care. Concurrently, enhancements in reprocessing protocols and accessory design have elevated expectations for reusable platforms, prompting manufacturers to invest in innovations that reduce contamination risk and streamline end-user workflows.
In addition, the integration of digital tools and connectivity features is enabling richer clinical documentation and remote support capabilities. These shifts are occurring alongside heightened scrutiny of device lifecycles and a growing interest in sustainability across procurement functions. As a result, competitive dynamics are evolving: incumbents are enhancing their portfolios with modular upgrades and service offerings, and new entrants are targeting niche clinical needs with differentiated single-use or hybrid solutions. Taken together, these trends signal a market that is recalibrating around safety, performance, and the economics of use, and they set the context for how stakeholders will prioritize investments over the near to medium term.
Assessment of how 2025 tariff adjustments intensify supply chain and procurement complexity, driving localization, portfolio prioritization, and contractual flexibility
The cumulative impact of tariff adjustments announced for 2025 introduces a layer of complexity for manufacturers, distributors, and end users of gastrointestinal videoscopes. Tariff changes influence supply chain decisions, sourcing strategies, and regional pricing structures, requiring stakeholders to reassess procurement pathways and supplier relationships. Manufacturers with diversified production footprints and flexible component sourcing are positioned to mitigate immediate cost disruptions, while players reliant on concentrated manufacturing or single-source suppliers may face elevated margin pressure or the need to absorb cost increases.
For healthcare providers, tariff-driven cost pressures may translate into elongated procurement cycles as purchasing teams evaluate comparative bids, total cost of ownership, and service contract structures. In response, some suppliers may accelerate localization of certain manufacturing or assembly steps to contain tariff exposure, and others may renegotiate trade terms with logistics and component partners to preserve competitiveness. Moreover, tariff shifts often catalyze strategic conversations about product portfolio optimization, leading to prioritized investment in models and accessories that deliver clear clinical differentiation and minimize supply-chain vulnerability. Overall, the tariff environment heightens the premium on supply-chain agility, contractual flexibility, and regional manufacturing choices that align cost containment with continuity of care.
In-depth segmentation insights clarifying how scope types, device choices, clinical applications, end-user demands, resolution tiers, and sensor technologies drive procurement and innovation
Segmentation-centric insights reveal where clinical needs and purchasing behaviors intersect across device classes and deployment contexts. Based on scope type, colonoscopes, duodenoscopes, enteroscopes, and gastroscopes each follow distinct adoption trajectories; colonoscopes warrant special attention because the category includes both reusable and single-use options and, within reusable variants, the distinction between enhanced reprocessing and standard reprocessing drives procurement choices and clinical trust. When examined by device type, the fundamental split between reusable and single-use platforms raises trade-offs between per-procedure economics and infection-control gains, with reusable systems further differentiated by the presence or absence of enhanced reprocessing pathways.
Application-level segmentation underscores how diagnostic workflows and therapeutic interventions shape device specifications. Diagnostic use cases emphasize biopsy and high-fidelity imaging capabilities that support lesion detection, whereas therapeutic procedures prioritize functional attributes necessary for dilatation, hemostasis, and polypectomy. End-user segmentation highlights divergent priorities between ambulatory surgical centers, clinics, and hospitals; within hospitals, the private and public subsegments present different procurement cycles, budgetary constraints, and service expectations. Resolution-based segmentation distinguishes between high definition and standard definition systems, with high definition platforms divided into 1080P and 4K tiers that influence clinician preference and downstream analytics. Finally, technology segmentation contrasts CCD and CMOS sensor families, with CMOS further split into back-illuminated and front-illuminated variants that offer differing performance envelopes for low-light imaging and miniaturization. Synthesizing these segmentation lenses clarifies where product development, marketing, and clinical training investments will yield the greatest commercial return.
Regional operating realities and adoption dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that dictate procurement, regulation, and commercial strategy
Regional dynamics shape adoption pathways and competitive priorities across the Americas, Europe, Middle East & Africa, and Asia-Pacific, each presenting distinct regulatory milieus, reimbursement frameworks, and hospital infrastructure profiles. In the Americas, demand is frequently driven by a combination of guideline-aligned screening programs and a strong emphasis on infection prevention, which together influence a willingness to trial single-use devices in specific clinical contexts. Moving to Europe, Middle East & Africa, procurement decisions are often influenced by national-level health technology assessments, regional consortium buying, and a diverse set of public-private delivery models that affect the pace of capital equipment refresh and the uptake of reprocessing innovations.
In the Asia-Pacific region, rapid modernization of hospital infrastructure in many markets, coupled with strategic local manufacturing investments, is fostering a dynamic competitive landscape where both global suppliers and domestic producers compete on price, service, and localized feature sets. Across all regions, local regulatory expectations and clinical practice patterns determine which device attributes are prioritized, and transitions in regional supply chains-such as in-country assembly or component sourcing-are influencing lead times and after-sales support arrangements. Taken together, these regional insights illuminate where tailored go-to-market strategies and regulatory navigation will be most consequential for adoption and long-term market presence.
Competitive and strategic company dynamics emphasizing platform extensibility, service excellence, and partnerships that drive adoption and long-term customer relationships
Competitive dynamics among suppliers are shaped by product breadth, after-sales service capabilities, and the ability to supply integrated solutions that address clinical, operational, and lifecycle management needs. Market leaders tend to invest in platform architectures that support both incremental hardware upgrades and software-enabled feature enhancements, enabling long-term relationships with large hospital systems and ambulatory providers. At the same time, smaller and niche players are focusing on differentiated propositions-such as single-use technologies, modular optics, or integrated reprocessing solutions-that address specific clinical or infection-control pain points and can accelerate adoption in targeted settings.
Strategic imperatives for suppliers include bolstering service networks to reduce downtime, offering training and clinical support that demonstrably improve procedural outcomes, and aligning product roadmaps with evolving regulatory expectations for device safety and traceability. Partnerships and channel strategies are also critical: distribution agreements, clinical partnerships, and collaborations with reprocessing solution providers amplify reach and make complex value propositions easier to adopt. Additionally, the pressure to demonstrate sustainability and reduce life-cycle environmental impact is prompting companies to evaluate materials, packaging, and logistics, further differentiating those suppliers that can substantively reduce institutional burden while maintaining clinical performance.
Actionable recommendations for industry leaders to align product innovation, service excellence, supply chain resilience, and sustainability with evolving clinical and procurement priorities
Industry leaders should take a multi-dimensional approach to remain competitive as clinical expectations and procurement practices evolve. First, prioritize investments that deliver measurable clinical value-upgrades in imaging resolution, sensor sensitivity, and ergonomic design should be justified by improved diagnostic confidence or procedural efficiency. Second, strengthen service and training ecosystems to reduce adoption friction and showcase real-world performance gains; rapid-response technical support and clinician education programs materially influence purchasing decisions and long-term satisfaction.
Third, consider portfolio strategies that balance reusable and single-use offerings, aligned to distinct clinical scenarios and institutional risk tolerances, while ensuring that reprocessing pathways meet enhanced safety standards where applied. Fourth, de-risk supply chains through diversification of manufacturing sites and flexible sourcing agreements to mitigate tariff and logistics volatility. Fifth, adopt modular product architectures and open digital interfaces to facilitate software updates and third-party integrations, which extend platform lifespans and unlock additional revenue streams. Finally, integrate sustainability metrics into product design and packaging strategies to address institutional ESG priorities and differentiate offerings in procurement evaluations. By operationalizing these recommendations, organizations can align innovation with customer needs and preserve adaptability in a shifting market environment.
Robust mixed-methods research methodology combining clinician interviews, technical validation, and cross-checked secondary sources to ensure rigorous and actionable insights
The research underpinning this report employs a mixed-methods approach combining structured primary interviews, targeted expert consultations, and systematic secondary research to construct a robust evidence base. Primary research included in-depth interviews with clinicians, procurement officers, and service managers across hospitals, ambulatory surgical centers, and clinics to surface real-world priorities, adoption barriers, and procedural workflow implications. These insights were cross-referenced with device specification reviews, regulatory filings, and clinical literature to validate claims about performance characteristics and safety considerations.
Secondary research drew on technical whitepapers, peer-reviewed clinical studies, device labelling, and publicly available regulatory guidance to establish baseline fact sets for device categories and reprocessing standards. Data triangulation techniques were applied to reconcile differences between primary insights and documentary evidence, and analytic frameworks such as scenario mapping and sensitivity analysis were used to evaluate strategic implications. Quality assurance protocols included peer review by domain experts and consistency checks to ensure that conclusions are supported by multiple independent lines of evidence. This methodology ensures that findings are analytically rigorous, clinically grounded, and operationally relevant for decision-makers.
A concise conclusion synthesizing technological, clinical, and commercial imperatives to guide procurement and innovation decisions in gastrointestinal endoscopy
In conclusion, the gastrointestinal videoscopes landscape is at a pivotal moment where technological advances, heightened infection control priorities, and shifting trade dynamics intersect to reshape procurement and clinical practice. Stakeholders who proactively adapt-by embracing modular upgrades, reinforcing service and training capabilities, and implementing supply-chain resilience measures-will be better positioned to meet clinical demands while managing cost and operational risk. Simultaneously, nuanced segmentation strategies and regionally tailored approaches will determine where investments translate into sustainable adoption.
As institutions evaluate device options, the critical differentiators will be demonstrable clinical outcomes, reprocessing and safety assurances, and the totality of support services that underpin long-term platform value. By synthesizing segmentation-level insights, regional nuances, and company-level strategic options, decision-makers can create evidence-based purchasing pathways that enhance patient care while aligning with institutional priorities. The conclusion reinforces the report’s role as a decision support tool to guide procurement, innovation, and partnership decisions in this evolving market.
Note: PDF & Excel + Online Access - 1 Year
A focused introduction that frames the gastrointestinal videoscopes landscape, clinical applications, and the analytical approach guiding strategic insights
The gastrointestinal videoscopes market sits at the nexus of clinical need, technological innovation, and evolving infection control expectations. This report opens with a concise orientation to the landscape, articulating the devices under consideration, the primary clinical applications they serve, and the operational environments in which they are deployed. The introduction frames the report’s scope and methodology while laying out the key themes that recur throughout the analysis, including device lifecycle management, reprocessing practices, and image resolution trends that influence purchasing decisions and clinical workflows.
Clinicians and administrators alike face a balance between patient safety, procedural efficiency, and capital planning. Therefore, the narrative emphasizes how incremental improvements in imaging and sensor technology can translate into diagnostic clarity and therapeutic precision. The introduction underscores the interplay between regulatory expectations and commercial strategy, setting the stage for subsequent sections that examine market shifts, tariff impacts, segmentation-level insights, and regional dynamics. By establishing this foundation, readers will gain clarity on the report’s objectives and the analytical lenses applied to synthesize cross-functional intelligence for stakeholders across clinical, procurement, and manufacturing roles.
Transformative shifts reshaping clinical practice, device stewardship, and commercial competition as safety, imaging performance, and single-use options gain prominence
The landscape for gastrointestinal videoscopes is undergoing transformative shifts driven by converging pressures from clinicians, regulators, and technology providers. Advances in sensor architectures and optics are improving image fidelity, while the rise of single-use devices is reshaping conversations about infection control, operational throughput, and total cost of care. Concurrently, enhancements in reprocessing protocols and accessory design have elevated expectations for reusable platforms, prompting manufacturers to invest in innovations that reduce contamination risk and streamline end-user workflows.
In addition, the integration of digital tools and connectivity features is enabling richer clinical documentation and remote support capabilities. These shifts are occurring alongside heightened scrutiny of device lifecycles and a growing interest in sustainability across procurement functions. As a result, competitive dynamics are evolving: incumbents are enhancing their portfolios with modular upgrades and service offerings, and new entrants are targeting niche clinical needs with differentiated single-use or hybrid solutions. Taken together, these trends signal a market that is recalibrating around safety, performance, and the economics of use, and they set the context for how stakeholders will prioritize investments over the near to medium term.
Assessment of how 2025 tariff adjustments intensify supply chain and procurement complexity, driving localization, portfolio prioritization, and contractual flexibility
The cumulative impact of tariff adjustments announced for 2025 introduces a layer of complexity for manufacturers, distributors, and end users of gastrointestinal videoscopes. Tariff changes influence supply chain decisions, sourcing strategies, and regional pricing structures, requiring stakeholders to reassess procurement pathways and supplier relationships. Manufacturers with diversified production footprints and flexible component sourcing are positioned to mitigate immediate cost disruptions, while players reliant on concentrated manufacturing or single-source suppliers may face elevated margin pressure or the need to absorb cost increases.
For healthcare providers, tariff-driven cost pressures may translate into elongated procurement cycles as purchasing teams evaluate comparative bids, total cost of ownership, and service contract structures. In response, some suppliers may accelerate localization of certain manufacturing or assembly steps to contain tariff exposure, and others may renegotiate trade terms with logistics and component partners to preserve competitiveness. Moreover, tariff shifts often catalyze strategic conversations about product portfolio optimization, leading to prioritized investment in models and accessories that deliver clear clinical differentiation and minimize supply-chain vulnerability. Overall, the tariff environment heightens the premium on supply-chain agility, contractual flexibility, and regional manufacturing choices that align cost containment with continuity of care.
In-depth segmentation insights clarifying how scope types, device choices, clinical applications, end-user demands, resolution tiers, and sensor technologies drive procurement and innovation
Segmentation-centric insights reveal where clinical needs and purchasing behaviors intersect across device classes and deployment contexts. Based on scope type, colonoscopes, duodenoscopes, enteroscopes, and gastroscopes each follow distinct adoption trajectories; colonoscopes warrant special attention because the category includes both reusable and single-use options and, within reusable variants, the distinction between enhanced reprocessing and standard reprocessing drives procurement choices and clinical trust. When examined by device type, the fundamental split between reusable and single-use platforms raises trade-offs between per-procedure economics and infection-control gains, with reusable systems further differentiated by the presence or absence of enhanced reprocessing pathways.
Application-level segmentation underscores how diagnostic workflows and therapeutic interventions shape device specifications. Diagnostic use cases emphasize biopsy and high-fidelity imaging capabilities that support lesion detection, whereas therapeutic procedures prioritize functional attributes necessary for dilatation, hemostasis, and polypectomy. End-user segmentation highlights divergent priorities between ambulatory surgical centers, clinics, and hospitals; within hospitals, the private and public subsegments present different procurement cycles, budgetary constraints, and service expectations. Resolution-based segmentation distinguishes between high definition and standard definition systems, with high definition platforms divided into 1080P and 4K tiers that influence clinician preference and downstream analytics. Finally, technology segmentation contrasts CCD and CMOS sensor families, with CMOS further split into back-illuminated and front-illuminated variants that offer differing performance envelopes for low-light imaging and miniaturization. Synthesizing these segmentation lenses clarifies where product development, marketing, and clinical training investments will yield the greatest commercial return.
Regional operating realities and adoption dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that dictate procurement, regulation, and commercial strategy
Regional dynamics shape adoption pathways and competitive priorities across the Americas, Europe, Middle East & Africa, and Asia-Pacific, each presenting distinct regulatory milieus, reimbursement frameworks, and hospital infrastructure profiles. In the Americas, demand is frequently driven by a combination of guideline-aligned screening programs and a strong emphasis on infection prevention, which together influence a willingness to trial single-use devices in specific clinical contexts. Moving to Europe, Middle East & Africa, procurement decisions are often influenced by national-level health technology assessments, regional consortium buying, and a diverse set of public-private delivery models that affect the pace of capital equipment refresh and the uptake of reprocessing innovations.
In the Asia-Pacific region, rapid modernization of hospital infrastructure in many markets, coupled with strategic local manufacturing investments, is fostering a dynamic competitive landscape where both global suppliers and domestic producers compete on price, service, and localized feature sets. Across all regions, local regulatory expectations and clinical practice patterns determine which device attributes are prioritized, and transitions in regional supply chains-such as in-country assembly or component sourcing-are influencing lead times and after-sales support arrangements. Taken together, these regional insights illuminate where tailored go-to-market strategies and regulatory navigation will be most consequential for adoption and long-term market presence.
Competitive and strategic company dynamics emphasizing platform extensibility, service excellence, and partnerships that drive adoption and long-term customer relationships
Competitive dynamics among suppliers are shaped by product breadth, after-sales service capabilities, and the ability to supply integrated solutions that address clinical, operational, and lifecycle management needs. Market leaders tend to invest in platform architectures that support both incremental hardware upgrades and software-enabled feature enhancements, enabling long-term relationships with large hospital systems and ambulatory providers. At the same time, smaller and niche players are focusing on differentiated propositions-such as single-use technologies, modular optics, or integrated reprocessing solutions-that address specific clinical or infection-control pain points and can accelerate adoption in targeted settings.
Strategic imperatives for suppliers include bolstering service networks to reduce downtime, offering training and clinical support that demonstrably improve procedural outcomes, and aligning product roadmaps with evolving regulatory expectations for device safety and traceability. Partnerships and channel strategies are also critical: distribution agreements, clinical partnerships, and collaborations with reprocessing solution providers amplify reach and make complex value propositions easier to adopt. Additionally, the pressure to demonstrate sustainability and reduce life-cycle environmental impact is prompting companies to evaluate materials, packaging, and logistics, further differentiating those suppliers that can substantively reduce institutional burden while maintaining clinical performance.
Actionable recommendations for industry leaders to align product innovation, service excellence, supply chain resilience, and sustainability with evolving clinical and procurement priorities
Industry leaders should take a multi-dimensional approach to remain competitive as clinical expectations and procurement practices evolve. First, prioritize investments that deliver measurable clinical value-upgrades in imaging resolution, sensor sensitivity, and ergonomic design should be justified by improved diagnostic confidence or procedural efficiency. Second, strengthen service and training ecosystems to reduce adoption friction and showcase real-world performance gains; rapid-response technical support and clinician education programs materially influence purchasing decisions and long-term satisfaction.
Third, consider portfolio strategies that balance reusable and single-use offerings, aligned to distinct clinical scenarios and institutional risk tolerances, while ensuring that reprocessing pathways meet enhanced safety standards where applied. Fourth, de-risk supply chains through diversification of manufacturing sites and flexible sourcing agreements to mitigate tariff and logistics volatility. Fifth, adopt modular product architectures and open digital interfaces to facilitate software updates and third-party integrations, which extend platform lifespans and unlock additional revenue streams. Finally, integrate sustainability metrics into product design and packaging strategies to address institutional ESG priorities and differentiate offerings in procurement evaluations. By operationalizing these recommendations, organizations can align innovation with customer needs and preserve adaptability in a shifting market environment.
Robust mixed-methods research methodology combining clinician interviews, technical validation, and cross-checked secondary sources to ensure rigorous and actionable insights
The research underpinning this report employs a mixed-methods approach combining structured primary interviews, targeted expert consultations, and systematic secondary research to construct a robust evidence base. Primary research included in-depth interviews with clinicians, procurement officers, and service managers across hospitals, ambulatory surgical centers, and clinics to surface real-world priorities, adoption barriers, and procedural workflow implications. These insights were cross-referenced with device specification reviews, regulatory filings, and clinical literature to validate claims about performance characteristics and safety considerations.
Secondary research drew on technical whitepapers, peer-reviewed clinical studies, device labelling, and publicly available regulatory guidance to establish baseline fact sets for device categories and reprocessing standards. Data triangulation techniques were applied to reconcile differences between primary insights and documentary evidence, and analytic frameworks such as scenario mapping and sensitivity analysis were used to evaluate strategic implications. Quality assurance protocols included peer review by domain experts and consistency checks to ensure that conclusions are supported by multiple independent lines of evidence. This methodology ensures that findings are analytically rigorous, clinically grounded, and operationally relevant for decision-makers.
A concise conclusion synthesizing technological, clinical, and commercial imperatives to guide procurement and innovation decisions in gastrointestinal endoscopy
In conclusion, the gastrointestinal videoscopes landscape is at a pivotal moment where technological advances, heightened infection control priorities, and shifting trade dynamics intersect to reshape procurement and clinical practice. Stakeholders who proactively adapt-by embracing modular upgrades, reinforcing service and training capabilities, and implementing supply-chain resilience measures-will be better positioned to meet clinical demands while managing cost and operational risk. Simultaneously, nuanced segmentation strategies and regionally tailored approaches will determine where investments translate into sustainable adoption.
As institutions evaluate device options, the critical differentiators will be demonstrable clinical outcomes, reprocessing and safety assurances, and the totality of support services that underpin long-term platform value. By synthesizing segmentation-level insights, regional nuances, and company-level strategic options, decision-makers can create evidence-based purchasing pathways that enhance patient care while aligning with institutional priorities. The conclusion reinforces the report’s role as a decision support tool to guide procurement, innovation, and partnership decisions in this evolving market.
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
182 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Growing adoption of single-use gastrointestinal videoscopes to minimize cross contamination risks
- 5.2. Integration of artificial intelligence image analysis for real-time lesion detection in gastrointestinal endoscopy
- 5.3. Advancements in high-definition and 4K imaging technologies enhancing mucosal visualization in GI procedures
- 5.4. Emerging wireless capsule endoscopy systems enabling noninvasive diagnostics and enhanced patient comfort
- 5.5. Expansion of tele-endoscopy platforms extending remote diagnostics and specialist consultations in rural areas
- 5.6. Development of ultra-slim transnasal endoscopes designed for improved patient tolerability and faster procedures
- 5.7. Focus on cost-effective automated endoscope reprocessing solutions to optimize sterilization efficiency
- 5.8. Growth of pediatric and bariatric gastrointestinal endoscopy tools customized for specialized patient needs
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Gastrointestinal Videoscopes Market, by Scope Type
- 8.1. Colonoscope
- 8.1.1. Reusable
- 8.1.1.1. Enhanced Reprocessing
- 8.1.1.2. Standard
- 8.1.2. Single Use
- 8.2. Duodenoscope
- 8.3. Enteroscope
- 8.4. Gastroscope
- 9. Gastrointestinal Videoscopes Market, by Device Type
- 9.1. Reusable
- 9.1.1. Enhanced Reprocessing
- 9.1.2. Standard
- 9.2. Single Use
- 10. Gastrointestinal Videoscopes Market, by Resolution
- 10.1. High Definition
- 10.1.1. 1080P
- 10.1.2. 4K
- 10.2. Standard Definition
- 11. Gastrointestinal Videoscopes Market, by Technology
- 11.1. CCD
- 11.2. CMOS
- 11.2.1. Back Illuminated
- 11.2.2. Front Illuminated
- 12. Gastrointestinal Videoscopes Market, by Application
- 12.1. Diagnostic
- 12.1.1. Biopsy
- 12.1.2. Imaging
- 12.2. Therapeutic
- 12.2.1. Dilatation
- 12.2.2. Hemostasis
- 12.2.3. Polypectomy
- 13. Gastrointestinal Videoscopes Market, by End User
- 13.1. Ambulatory Surgical Centers
- 13.2. Clinics
- 13.3. Hospitals
- 13.3.1. Private
- 13.3.2. Public
- 14. Gastrointestinal Videoscopes Market, by Region
- 14.1. Americas
- 14.1.1. North America
- 14.1.2. Latin America
- 14.2. Europe, Middle East & Africa
- 14.2.1. Europe
- 14.2.2. Middle East
- 14.2.3. Africa
- 14.3. Asia-Pacific
- 15. Gastrointestinal Videoscopes Market, by Group
- 15.1. ASEAN
- 15.2. GCC
- 15.3. European Union
- 15.4. BRICS
- 15.5. G7
- 15.6. NATO
- 16. Gastrointestinal Videoscopes Market, by Country
- 16.1. United States
- 16.2. Canada
- 16.3. Mexico
- 16.4. Brazil
- 16.5. United Kingdom
- 16.6. Germany
- 16.7. France
- 16.8. Russia
- 16.9. Italy
- 16.10. Spain
- 16.11. China
- 16.12. India
- 16.13. Japan
- 16.14. Australia
- 16.15. South Korea
- 17. Competitive Landscape
- 17.1. Market Share Analysis, 2024
- 17.2. FPNV Positioning Matrix, 2024
- 17.3. Competitive Analysis
- 17.3.1. Ambu A/S
- 17.3.2. B. Braun Melsungen AG
- 17.3.3. Becton, Dickinson and Company
- 17.3.4. CONMED Corporation
- 17.3.5. ConvaTec
- 17.3.6. EndoChoice Holdings, Inc.
- 17.3.7. Ethicon Endo-Surgery, LLC
- 17.3.8. Hoya Corporation
- 17.3.9. Machida Endoscope Co., Ltd.
- 17.3.10. Micro-Tech (Nanjing) Co., Ltd.
- 17.3.11. Richard Wolf GmbH
- 17.3.12. Shenzhen Anke High-tech Co., Ltd.
- 17.3.13. Shenzhen Bestman Instrument Co., Ltd.
- 17.3.14. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- 17.3.15. SonoScape Medical Corp.
- 17.3.16. STERIS plc
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
